Deferasirox 43598-0856-90
- Manufacturer
- Dr. Reddy's Laboratories Inc
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 20, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA209878
Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferasirox | 250 mg/1 |
Drug Class
Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Selected Package
43598-0856-90Selected90 TABLET, FOR SUSPENSION in 1 BOTTLE (43598-856-90)
Other packages for this product(2)
1000 TABLET, FOR SUSPENSION in 1 BOTTLE (43598-856-10)
30 TABLET, FOR SUSPENSION in 1 BOTTLE (43598-856-30)